scispace - formally typeset
I

Irena Nulman

Researcher at University of Toronto

Publications -  93
Citations -  5934

Irena Nulman is an academic researcher from University of Toronto. The author has contributed to research in topics: Pregnancy & Population. The author has an hindex of 37, co-authored 92 publications receiving 5561 citations. Previous affiliations of Irena Nulman include Hospital for Sick Children.

Papers
More filters
Journal ArticleDOI

Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies

TL;DR: Although prednisone does not represent a major teratogenic risk in humans at therapeutic doses, it does increase by an order of 3.4-fold the risk of oral cleft, which is consistent with the existing animal studies.
Journal ArticleDOI

Neurodevelopment of Children Exposed in Utero to Antidepressant Drugs

TL;DR: In utero exposure to either tricyclic antidepressant drugs or fluoxetine does not affect global IQ, language development, or behavioral development in preschool children.
Journal ArticleDOI

Child Development Following Exposure to Tricyclic Antidepressants or Fluoxetine Throughout Fetal Life: A Prospective, Controlled Study

TL;DR: Exposure to tricyclic antidepressants or fluoxetine throughout gestation does not appear to adversely affect cognition, language development, or the temperament of preschool and early-school children, whereas mothers' depression is associated with less cognitive and language achievement by their children.
Book ChapterDOI

Fetal Alcohol Spectrum Disorder

TL;DR: Case Ms. L, a 32-year-old G5 P2 A2 (gravida 5, para 2, abortions 2) woman, is admitted to hospital because of premature rupture of membranes at an estimated 34 weeks of gestation.
Journal ArticleDOI

Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis.

TL;DR: Aspirin exposure during the first trimester of pregnancy may be associated with an increased risk of gastroschisis, but there is no evidence of an overall increase in the risk of congenital malformations that could been associated with aspirin.